Sarah Rodrigue

Sarah’s experience includes advising: 

• Olink Holding AB (publ) in its US$3.1 billion sale to Thermo Fisher Scientific* 
• A NASDAQ-listed digital transformation solutions and services company in its sale to a European IT solutions company via tender offer, in addition to corporate governance matters* 
• A NYSE-listed metal coating services company in its US$320 million underwritten public offering, in addition to corporate governance matters*
• Imunon Inc. in connection with numerous registered securities offerings, “at-the-market” securities offerings and other corporate governance matters* 
• A privately-held transmission and distribution utility company in numerous 144A/Reg. S offerings of senior secured notes and the related A/B exchange offers* 
• A NASDAQ-listed oncology drug development company in its successful uplisting to NASDAQ and various registered securities offerings of its shares of common and preferred stock, including a private investment in public equity (PIPE) offering* 
• Sanofi in the sale of its generics business in Colombia, Peru, and Ecuador* 
• A private equity fund group in the disposition of its portfolio companies* 
• A South Korean textile maker and supplier on the acquisition of a US sportswear maker*
• A NYSE-listed distributor of motor fuel on the acquisition of European liquid fuels terminals* 
• A multinational enterprise software company in the US$2.7 billion sale of its enterprise asset management division to an international industrial technology company* 
• A global computer security software company on the US$4 billion divestiture of its enterprise business* 

*Matter handled prior to joining Latham